Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...
The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...
Terminally ill Floridians could be given additional options to end their lives after a new measure was filed Friday. The bill ...
The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...
Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...
Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...
7d
Daily Voice Tolland County CT on MSNNon-Opioid Pain Medication Journavx Gets FDA ApprovalThe Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...
2d
Hosted on MSNNew bill would ban medication abortions: What’s in HR 629?A new bill has been introduced into United States Legislature that would prohibit the use of medication abortions in the ...
Medical Xpress on MSN11d
Adderall shortage may be associated with increased use of alternative ADHD medication in childrenStudy suggests that the Adderall shortage did not cause many children to stop stimulant therapy altogether but may have led to some switching to alternative stimulants for ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results